October Clinical Trial Feature: ROUTE T1D
Study Name: Research on Optimizing the Use of Technology With Education (ROUTE-T1D) (NCT05564481) Location: Children’s National Hospital Washington, DC Purpose…
Meet our 2023-2024 Mid-Atlantic Youth Ambassadors
The Breakthrough T1D Youth Ambassador (YA) Program provides the opportunity for youth leaders in grades K-12 who are living with…
Introducing Our New Clinical Trials Education Volunteer: Sidney Smith
In addition to Tom Brobson, introduced previously, Sidney Smith has joined the chapter as a Clinical Trials Education Volunteer. Breakthrough…
Great Seeing You at the 2023 Summits!
Thanks to all who attended a Mid-Atlantic TypeOneNation Summit in March! We had two incredible events with over 500 attendees…
CGM Research Study Seeks Adults with Type 2 Diabetes Participants
UVA Health System Center for Diabetes Technology seeks adults between the ages of 18-80 who have type 2 diabetes to…
UVA Clinical Research Study Seeks Adults with T1D
UVA Health System is looking for adults between the ages of 18-70 who have type 1 diabetes to participate in…
Seeking Participants for Clinical Trial
DRINK-T1D: A randomized clinical trial of effects of low-calorie sweetener restriction in children with type 1 diabetes is underway at Children’s…
What You Need to Know About the ADA Scientific Sessions with Breakthrough T1D CEO Aaron Kowalski
On Thursday, July 7 at 6:00 PM ET join Breakthrough T1D CEO Aaron Kowalski, Ph.D. for an overview of the…
Ground-Breaking Clinical Trial at VCU in Richmond, VA
Vertex Pharmaceuticals has launched a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D)…
Breakthrough T1D TypeOneNation Virtual Summit – Viviendo sin Limites
¡Nos emociona mucho compartir que el 31 de julio, la Alianza Breakthrough T1D- Beyond Type 1 será la anfitriona del…
